The Potential of Albuminuria as a Biomarker of Diabetic Complications.

Cardiovascular Drugs and Therapy
Pappitha RajaDerek P Brazil

Abstract

Diabetes mellitus is a disease of dysregulated blood glucose homeostasis. The current pandemic of diabetes is a significant driver of patient morbidity and mortality, as well as a major challenge to healthcare systems worldwide. The global increase in the incidence of diabetes has prompted researchers to focus on the different pathogenic processes responsible for type 1 and type 2 diabetes. Similarly, increased morbidity due to diabetic complications has accelerated research to uncover pathological changes causing these secondary complications. Albuminuria, or protein in the urine, is a well-recognised biomarker and risk factor for renal and cardiovascular disease. Albuminuria is a mediator of pathological abnormalities in diabetes-associated conditions such as nephropathy and atherosclerosis. Clinical screening and diagnosis of diabetic nephropathy is chiefly based on the presence of albuminuria. Given the ease in measuring albuminuria, the potential of using albuminuria as a biomarker of cardiovascular diseases is gaining widespread interest. To assess the benefits of albuminuria as a biomarker, it is important to understand the association between albuminuria and cardiovascular disease. This review examines our current under...Continue Reading

References

Apr 1, 1981·Australian and New Zealand Journal of Medicine·G B Ryan
Apr 16, 1998·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·W E Smoyer, P Mundel
Dec 13, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Bengt Rippe
Oct 7, 2004·Molecular Genetics and Metabolism·Myung-Shik LeeSunshin Kim
Feb 3, 2005·Current Hypertension Reports·Janaka Karalliedde, Giancarlo Viberti
Jun 7, 2005·Journal of the American Society of Nephrology : JASN·Francesco P Schena, Loreto Gesualdo
Jul 15, 2005·Kidney International. Supplement·Aida Jimenez CoronaClicerio Gonzalez-Villalpando
Sep 20, 2005·Journal of Molecular Biology·Jamie GhumanStephen Curry
Mar 4, 2006·Kidney International·H Birn, E I Christensen
Mar 28, 2006·Journal of the American Society of Nephrology : JASN·Giuseppe RemuzziPiero Ruggenenti
Nov 4, 2006·Journal of the American Society of Nephrology : JASN·Mitsuo KatoRama Natarajan
Aug 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Matthew R Weir
Dec 17, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ron T Gansevoort, Eberhard Ritz
Nov 13, 2009·Diabetes Care·Simon R Heller, UNKNOWN ADVANCE Collaborative Group
Nov 7, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hiroyuki ItoMichiko Togane
Dec 17, 2009·The American Journal of Pathology·Benjamin D HumphreysJeremy S Duffield
Mar 11, 2010·Advances in Experimental Medicine and Biology·Daria La Torre, Ake Lernmark
Aug 28, 2010·Journal of the American Society of Nephrology : JASN·Sabine AmsellemRenata Kozyraki
Oct 30, 2010·Journal of the American Society of Nephrology : JASN·Elena GagliardiniAndrea Remuzzi
Mar 1, 2011·Journal of the American Society of Nephrology : JASN·Carsten A BögerW H L Kao
Jan 11, 2013·Physiological Reviews·Josephine M Forbes, Mark E Cooper
Mar 27, 2013·Nature Reviews. Nephrology·Marcus J Moeller, Verena Tenten
Jun 19, 2013·Nature Reviews. Nephrology·Jung Hee Suh, Jeffrey H Miner
Aug 24, 2013·Journal of the American Society of Nephrology : JASN·Verena TentenMarcus J Moeller
Aug 31, 2013·JAMA : the Journal of the American Medical Association·Orlando M GutiérrezUNKNOWN REGARDS Investigators
Oct 2, 2013·Nature Reviews. Nephrology·Simon Satchell
Dec 21, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Jan 11, 2014·Journal of the American Society of Nephrology : JASN·Landon E DicksonBruce A Molitoris
Mar 14, 2014·Diabetes Care·Stefan PilzUNKNOWN RISC Investigators
Apr 7, 2011·Journal of Diabetes Investigation·Gil LeibowitzErol Cerasi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Related Papers

La Ricerca in Clinica E in Laboratorio
L Scarpioni
Belgisch tijdschrift voor geneeskunde
P BRUSSELMANS
Pediatria prática
R M GESTEIRA
British Medical Journal
A Clark
© 2021 Meta ULC. All rights reserved